Practice variation among Michigan neurologists in the use of intravenous heparin

Rashmi Kudesia, Seemant Chaturvedi

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Background/Objective: The indications for intravenous (IV) heparin use in acute ischemic stroke are uncertain. We sought to determine the current practice patterns of neurologists in Michigan with regard to IV heparin use, in view of the fact that several major multi-center trials evaluating heparin and related compounds have been completed in the last decade. Methods: A survey was conducted of 180 active, practicing neurologists in Michigan. Five clinical scenarios were included and factors influencing heparin use were also determined. Results: The vast majority of neurologists in Michigan would use IV heparin for patients with atrial fibrillation-related stroke (91% of those with a defined opinion). Heparin use was also popular for stroke-in-evolution (77%). There was a lesser degree of heparin use for patients with more than one transient ischemic attack (49%) or for patients with stroke and normal cardiac rhythm. Medicolegal factors at least sometimes influenced the selection of heparin as a therapy for 41% of physicians. Conclusions: Despite recent clinical trial data on heparin and related compounds which for the most part has been negative, IV heparin use remains popular for certain clinical scenarios, especially acute stroke with atrial fibrillation. Further studies are necessary to determine whether negative clinical trials have the same impact on neurologist behavior as positive studies.

Original languageEnglish (US)
Pages (from-to)25-27
Number of pages3
JournalJournal of the Neurological Sciences
Volume202
Issue number1-2
DOIs
StatePublished - Oct 15 2002
Externally publishedYes

Fingerprint

Heparin
Stroke
Atrial Fibrillation
Neurologists
Clinical Trials
Transient Ischemic Attack
Physicians

Keywords

  • Acute ischemic stroke
  • Anticoagulation
  • Atrial fibrillation
  • Heparin

ASJC Scopus subject areas

  • Aging
  • Clinical Neurology
  • Surgery
  • Developmental Neuroscience
  • Neurology
  • Neuroscience(all)

Cite this

Practice variation among Michigan neurologists in the use of intravenous heparin. / Kudesia, Rashmi; Chaturvedi, Seemant.

In: Journal of the Neurological Sciences, Vol. 202, No. 1-2, 15.10.2002, p. 25-27.

Research output: Contribution to journalArticle

@article{f14452d1fe6b4a4f8e443cb40d4ca98e,
title = "Practice variation among Michigan neurologists in the use of intravenous heparin",
abstract = "Background/Objective: The indications for intravenous (IV) heparin use in acute ischemic stroke are uncertain. We sought to determine the current practice patterns of neurologists in Michigan with regard to IV heparin use, in view of the fact that several major multi-center trials evaluating heparin and related compounds have been completed in the last decade. Methods: A survey was conducted of 180 active, practicing neurologists in Michigan. Five clinical scenarios were included and factors influencing heparin use were also determined. Results: The vast majority of neurologists in Michigan would use IV heparin for patients with atrial fibrillation-related stroke (91{\%} of those with a defined opinion). Heparin use was also popular for stroke-in-evolution (77{\%}). There was a lesser degree of heparin use for patients with more than one transient ischemic attack (49{\%}) or for patients with stroke and normal cardiac rhythm. Medicolegal factors at least sometimes influenced the selection of heparin as a therapy for 41{\%} of physicians. Conclusions: Despite recent clinical trial data on heparin and related compounds which for the most part has been negative, IV heparin use remains popular for certain clinical scenarios, especially acute stroke with atrial fibrillation. Further studies are necessary to determine whether negative clinical trials have the same impact on neurologist behavior as positive studies.",
keywords = "Acute ischemic stroke, Anticoagulation, Atrial fibrillation, Heparin",
author = "Rashmi Kudesia and Seemant Chaturvedi",
year = "2002",
month = "10",
day = "15",
doi = "10.1016/S0022-510X(02)00127-2",
language = "English (US)",
volume = "202",
pages = "25--27",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Practice variation among Michigan neurologists in the use of intravenous heparin

AU - Kudesia, Rashmi

AU - Chaturvedi, Seemant

PY - 2002/10/15

Y1 - 2002/10/15

N2 - Background/Objective: The indications for intravenous (IV) heparin use in acute ischemic stroke are uncertain. We sought to determine the current practice patterns of neurologists in Michigan with regard to IV heparin use, in view of the fact that several major multi-center trials evaluating heparin and related compounds have been completed in the last decade. Methods: A survey was conducted of 180 active, practicing neurologists in Michigan. Five clinical scenarios were included and factors influencing heparin use were also determined. Results: The vast majority of neurologists in Michigan would use IV heparin for patients with atrial fibrillation-related stroke (91% of those with a defined opinion). Heparin use was also popular for stroke-in-evolution (77%). There was a lesser degree of heparin use for patients with more than one transient ischemic attack (49%) or for patients with stroke and normal cardiac rhythm. Medicolegal factors at least sometimes influenced the selection of heparin as a therapy for 41% of physicians. Conclusions: Despite recent clinical trial data on heparin and related compounds which for the most part has been negative, IV heparin use remains popular for certain clinical scenarios, especially acute stroke with atrial fibrillation. Further studies are necessary to determine whether negative clinical trials have the same impact on neurologist behavior as positive studies.

AB - Background/Objective: The indications for intravenous (IV) heparin use in acute ischemic stroke are uncertain. We sought to determine the current practice patterns of neurologists in Michigan with regard to IV heparin use, in view of the fact that several major multi-center trials evaluating heparin and related compounds have been completed in the last decade. Methods: A survey was conducted of 180 active, practicing neurologists in Michigan. Five clinical scenarios were included and factors influencing heparin use were also determined. Results: The vast majority of neurologists in Michigan would use IV heparin for patients with atrial fibrillation-related stroke (91% of those with a defined opinion). Heparin use was also popular for stroke-in-evolution (77%). There was a lesser degree of heparin use for patients with more than one transient ischemic attack (49%) or for patients with stroke and normal cardiac rhythm. Medicolegal factors at least sometimes influenced the selection of heparin as a therapy for 41% of physicians. Conclusions: Despite recent clinical trial data on heparin and related compounds which for the most part has been negative, IV heparin use remains popular for certain clinical scenarios, especially acute stroke with atrial fibrillation. Further studies are necessary to determine whether negative clinical trials have the same impact on neurologist behavior as positive studies.

KW - Acute ischemic stroke

KW - Anticoagulation

KW - Atrial fibrillation

KW - Heparin

UR - http://www.scopus.com/inward/record.url?scp=0037110411&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037110411&partnerID=8YFLogxK

U2 - 10.1016/S0022-510X(02)00127-2

DO - 10.1016/S0022-510X(02)00127-2

M3 - Article

VL - 202

SP - 25

EP - 27

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -